• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在存在胎儿生长受限的情况下,对重度子痫前期进行期待治疗时,围产期及母体结局是否有所不同?

Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction?

作者信息

Haddad Bassam, Kayem Gilles, Deis Stephanie, Sibai Baha M

机构信息

Department of Obstetrics and Gynecology, University of Paris XII, Créteil, Paris, France.

出版信息

Am J Obstet Gynecol. 2007 Mar;196(3):237.e1-5. doi: 10.1016/j.ajog.2006.10.905.

DOI:10.1016/j.ajog.2006.10.905
PMID:17346535
Abstract

OBJECTIVE

The purpose of this study was to compare perinatal and maternal outcomes in women with singleton pregnancies and severe preeclampsia (SPE) expectantly managed at 24-33 weeks' gestation (wk) that resulted at birth in severe intrauterine growth restriction (SIUGR, < 5th percentile) to those without SIUGR.

STUDY DESIGN

Two hundred thirty-nine women undelivered after antenatal steroids were expectantly managed. Perinatal and maternal outcomes were analyzed according to fetal growth status. Students t-test, chi-square test, logistic regression analysis, and odds ratio were calculated.

RESULTS

Fifty-eight pregnancies resulted in an SIUGR neonate. Median latency periods (5 vs 5 d) and delivery gestational ages (30.6 vs 30.3 wk) were similar in the 2 groups. Controlling for gestational age at delivery, only fetal death remained associated with SIUGR (OR: 6.4; 95% CI 1.05-39.35, P = .04). Maternal outcomes were similar in the 2 groups.

CONCLUSION

In severe preeclamptic women at 24-33 weeks, SIUGR is associated with increased risk of fetal death but does not affect maternal complications.

摘要

目的

本研究旨在比较孕周为24 - 33周时期待治疗的单胎妊娠重度子痫前期(SPE)患者中,出生时发生严重宫内生长受限(SIUGR,低于第5百分位数)与未发生SIUGR患者的围产期及母体结局。

研究设计

对239例接受产前类固醇治疗后未分娩的患者进行期待治疗。根据胎儿生长状况分析围产期及母体结局。计算学生t检验、卡方检验、逻辑回归分析和比值比。

结果

58例妊娠分娩出SIUGR新生儿。两组的中位潜伏期(5天对5天)和分娩孕周(30.6周对30.3周)相似。在控制分娩孕周后,仅胎儿死亡与SIUGR相关(比值比:6.4;95%可信区间1.05 - 39.35,P = 0.04)。两组的母体结局相似。

结论

在孕周为24 - 33周的重度子痫前期女性中,SIUGR与胎儿死亡风险增加相关,但不影响母体并发症。

相似文献

1
Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction?在存在胎儿生长受限的情况下,对重度子痫前期进行期待治疗时,围产期及母体结局是否有所不同?
Am J Obstet Gynecol. 2007 Mar;196(3):237.e1-5. doi: 10.1016/j.ajog.2006.10.905.
2
Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation.239例孕24至33周重度子痫前期孕妇期待治疗期间的母儿结局。
Am J Obstet Gynecol. 2004 Jun;190(6):1590-5; discussion 1595-7. doi: 10.1016/j.ajog.2004.03.050.
3
Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery?重度早发型子痫前期的期待治疗:胎儿生长受限是否为立即分娩的指征?
Am J Obstet Gynecol. 2000 Oct;183(4):853-8. doi: 10.1067/mob.2000.109049.
4
Preeclampsia, gestational hypertension and intrauterine growth restriction, related or independent conditions?子痫前期、妊娠期高血压与胎儿生长受限,是相关还是独立的病症?
Am J Obstet Gynecol. 2006 Apr;194(4):921-31. doi: 10.1016/j.ajog.2005.10.813.
5
Perinatal outcomes in severe preeclamptic women between 24-33(+6) weeks' gestation.孕24至33(+6)周重度子痫前期女性的围产期结局
J Med Assoc Thai. 2008 Jan;91(1):25-30.
6
Benefits and risks of expectant management of severe preeclampsia at less than 26 weeks gestation: the impact of gestational age and severe fetal growth restriction.孕 26 周前严重子痫前期期待治疗的获益与风险:胎龄和严重胎儿生长受限的影响。
Am J Obstet Gynecol. 2011 Nov;205(5):465.e1-6. doi: 10.1016/j.ajog.2011.06.062. Epub 2011 Jun 24.
7
Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center.妊娠合并妊娠期高血压疾病的孕产妇及围产儿结局:一家三级医疗中心的七年经验
Arch Gynecol Obstet. 2005 Nov;273(1):43-9. doi: 10.1007/s00404-005-0741-3. Epub 2005 Apr 15.
8
Proteinuria in pre-eclampsia: how much matters?子痫前期中的蛋白尿:影响程度如何?
BJOG. 2005 Mar;112(3):280-5. doi: 10.1111/j.1471-0528.2004.00395.x.
9
Expectant management of severe preeclampsia presenting before 25 weeks of gestation.妊娠25周前出现的重度子痫前期的期待治疗。
Med Sci Monit. 2007 Nov;13(11):CR523-527.
10
The impact of fetal growth restriction on latency in the setting of expectant management of preeclampsia.期待治疗子痫前期时胎儿生长受限对潜伏期的影响。
Am J Obstet Gynecol. 2016 Mar;214(3):395.e1-7. doi: 10.1016/j.ajog.2015.12.050. Epub 2016 Jan 6.

引用本文的文献

1
Fetal growth restriction as the initial finding of preeclampsia is a clinical predictor of maternal and neonatal prognoses: a single-center retrospective study.胎儿生长受限作为子痫前期的首发表现是母婴预后的临床预测指标:一项单中心回顾性研究。
BMC Pregnancy Childbirth. 2021 Oct 6;21(1):678. doi: 10.1186/s12884-021-04152-2.
2
The expression of pentraxin 3 and tumor necrosis factor-alpha is increased in preeclamptic placental tissue and maternal serum.子痫前期胎盘组织和母血清中五聚素 3 和肿瘤坏死因子-α的表达增加。
Inflamm Res. 2012 Sep;61(9):1005-12. doi: 10.1007/s00011-012-0507-x. Epub 2012 Jun 20.
3
Is fetal growth restriction associated with a more severe maternal phenotype in the setting of early onset pre-eclampsia? A retrospective study.
早发型子痫前期患者中胎儿生长受限是否与更严重的母体表型相关?一项回顾性研究。
PLoS One. 2011;6(10):e26937. doi: 10.1371/journal.pone.0026937. Epub 2011 Oct 28.
4
Pre-eclampsia: pathophysiology, diagnosis, and management.子痫前期:病理生理学、诊断及管理
Vasc Health Risk Manag. 2011;7:467-74. doi: 10.2147/VHRM.S20181. Epub 2011 Jul 19.